Literature DB >> 8515265

The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical.

K Chen1, H F Wu, J C Shih.   

Abstract

Monoamine oxidases (MAOs) A and B play important roles in the metabolism of neuroactive, vasoactive amines. Human platelets contain only MAO B, often used as an indicator of brain MAO B. The validity of this model remained to be evaluated. This report describes the molecular cloning of human MAO B from frontal cortex and platelets. Two overlapping PCR-amplified clones of human platelet MAO B and four PCR-amplified clones of human frontal cortex MAO B covering the entire coding region were sequenced using five internal oligomers and M13 reverse and forward primers. The nucleotide sequences of human MAO B cDNA from platelet and frontal cortex were identical to that of human liver MAO B except for three nucleotides that differed in frontal cortex: nucleotides 440 A-->G, 794 C-->T, and 825 C-->T. Whether or not these differences are artifactual, all three represent silent mutations, which would not alter the amino acid of the encoded polypeptides. Thus, the deduced amino acid sequences of MAO B from frontal cortex, platelet, and liver are identical. These findings indicate the validity of using platelet MAO B mRNA as a marker for brain MAO B and provide a new approach to study the role of brain MAO B in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515265     DOI: 10.1111/j.1471-4159.1993.tb03554.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys.

Authors:  Hanna-Linn Wargelius; Claudia Fahlke; Stephen J Suomi; Lars Oreland; James Dee Higley
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

3.  Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.

Authors:  T May; A Greube; S Strauss; D Heineke; J Lehmann; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

4.  Risk factors for the neurohumoral alterations underlying personality disturbances.

Authors:  Lars Oreland; Mattias Damberg; Jarmila Hallman; Cecilia Berggård; Hakan Garpenstrand
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

5.  Hyperserotonemia in autism: activity of 5HT-associated platelet proteins.

Authors:  Dubravka Hranilović; Zorana Bujas-Petković; Maja Tomicić; Tatjana Bordukalo-Niksić; Sofia Blazević; Lipa Cicin-Sain
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

6.  Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice.

Authors:  R Ye; A M D Carneiro; D Airey; E Sanders-Bush; R W Williams; L Lu; J Wang; B Zhang; R D Blakely
Journal:  Genes Brain Behav       Date:  2013-10-31       Impact factor: 3.449

7.  No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls.

Authors:  Teresa Coccini; Luigi Manzo; Frodi Debes; Ulrike Steuerwald; Pal Weihe; Philippe Grandjean
Journal:  Biomarkers       Date:  2009-03       Impact factor: 2.658

8.  The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.

Authors:  R Alemany; G Olmos; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

9.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Authors:  J W Lenders; G Eisenhofer; N G Abeling; W Berger; D L Murphy; C H Konings; L M Wagemakers; I J Kopin; F Karoum; A H van Gennip; H G Brunner
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Application of Neurochemical Markers for Assessing Health Effects after Developmental Methylmercury and PCB Coexposure.

Authors:  E Roda; L Manzo; T Coccini
Journal:  J Toxicol       Date:  2012-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.